The Africa injectable drugs market is a highly lucrative segment within the pharmaceutical industry. Injectable drugs provide direct introduction of medication into the patient's body through intravenous, intramuscular, subcutaneous, or intrathecal routes thereby ensuring better absorption and enhanced bioavailability. The injectable route of administration finds widespread application in treatment of infectious diseases, cancer, cardiovascular disorders, metabolic diseases and other chronic health conditions. The growing burden of chronic diseases due to changing lifestyle habits and risk factors is a key driver augmenting the demand for injectable medications in African countries.
Africa injectable drugs market is estimated to be valued at US$ 284.5 Mn in 2022 and expected to exhibit a CAGR of 4.7% during the forecast period (2022-2030).
Key Takeaways
Key players: Key players operating in the Africa injectable drugs market are Apotex Inc., Fresenius Kabi India Pvt. Ltd., Hikma Pharmaceuticals PLC, Pfizer Inc., Bristol-Myers Squibb Company, Gland Pharma Limited, hameln pharma gmbh, Merck & Co., Inc., AbbVie Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, and PANPHARMA S.A.
Key opportunities: Rising healthcare expenditure of African governments, increasing research collaborations to develop drugs for Africa-centric diseases, and growing use of biosimilars present lucrative growth opportunities in the Africa injectable drugs market Demand.
Global expansion: Leading pharmaceutical companies are expanding their geographic presence in Africa through strategic acquisitions and partnerships. This is helping improve the accessibility and affordability of injectable drug therapies across major markets.
Market drivers: Increasing prevalence of chronic diseases such as diabetes, cancer and cardiovascular disorders major market driver for Africa injectable drugs market. According to WHO estimates, four out of five deaths in Africa are due to chronic diseases. As per new study published, Africa's chronic disease burden is projected to surpass infectious diseases by 2030. This rising burden of chronic conditions is expected to augment demand for injectable medications over the forecast period.
PEST Analysis
Political: The regulations surrounding drug approval and regulations in various African countries may differ, which affects market access and duration of protection of intellectual property.
Economic: Changes in economic growth, spending on healthcare, and reimbursement policies influence the demand potential for injectable drugs in Africa.
Social: Rising incomes, awareness, lifestyle changes, and aspects like aging population affecting disease demographics shape the uptake of injectable pharmaceutical solutions.
Technological: Advancements in drug delivery mechanisms, cold chain logistics, active pharmaceutical ingredients manufacturing, and connectivity are expanding the reach, efficacy, and adoption of injectable medications.
The most concentrated regions in terms of value are North Africa and Sub-Saharan Africa. North Africa has a higher healthcare expenditure compared to other African countries, which facilitates the uptake of injectable drugs. Sub-Saharan Africa accounts for over half the population of Africa and has a high disease burden, providing a large patient base for pharmaceutical interventions delivered via the injectable route.
The fastest growing region for the Africa injectable drugs market is expected to be East Africa from 2024 to 2031. Countries in East Africa like Ethiopia, Kenya, Tanzania, and Uganda are experiencing improvements in their economic conditions and healthcare investments. This is enabling better access to sophisticated treatments like injectable drugs alongside rising standards of living. Additionally, the youthful demographic profile of East African nations is contributing to their faster growth rates compared to other parts of the continent.
Get this Report in Japanese Language:
Get this Report in Korean Language:
About Author:
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)
Comments
0 comment